PFE PEER ANALYSIS

Pfizer Inc — metric-by-metric comparison with peers and the industry median

PFEPfizer Inc

🇺🇸 USA · US · Healthcare · Drug Manufacturers - General

Value it Duel

Overall Profile & Returns

· Drug Manufacturers - General

Position Within Industry

0 = weak quartile, 100 = strong quartile

PFEIndustry median

Scores normalize each metric against industry quartiles (p25–p75); direction is inverted for lower-is-better metrics.

Return Comparison

1-Year

Split-adjusted

Year-to-Date (YTD)

Key Metric Comparison

P/E

Lower is better

ROE

Higher is better

Net Margin

Higher is better

Revenue Growth

Higher is better

All Metrics

Valuation
Metric	PFE	SAN	BAYN	AZN	GRF	AZN	Ind. Median
P/E	18.61	8.81●	—	29.05	14.78	28.79	23.37
P/B	1.55	1.25	1.82	6.38	1.12●	6.36	4.60
EV/EBITDA	11.39	9.72●	24.14	16.08	10.50	15.93	13.81
P/S	2.20	1.97	1.16	4.99	0.83●	4.95	3.25

Financial Health
Metric	PFE	SAN	BAYN	AZN	GRF	AZN	Ind. Median
Current Ratio	1.25	1.01	1.06	0.91	2.47●	0.91	1.25
Debt/Equity	71.5%	27.5%●	134.8%	71.7%	177.2%	71.7%	94.3%
NetDebt/EBITDA	3.07	1.33	9.19	1.29	6.22	1.28●	1.35

Profitability
Metric	PFE	SAN	BAYN	AZN	GRF	AZN	Ind. Median
Net Margin	11.8%	22.3%●	-4.8%	17.2%	5.6%	17.2%	15.0%
ROE	8.3%	14.1%	-7.0%	23.5%	7.5%	23.7%●	23.7%
ROA	3.6%	8.0%	-2.0%	9.4%	2.0%	9.5%●	8.0%
EBITDA Margin	26.5%	23.4%	7.7%	33.7%	19.3%	33.8%●	28.4%

Growth + Dividend
Metric	PFE	SAN	BAYN	AZN	GRF	AZN	Ind. Median
Rev. Growth	1.4%	3.3%	-2.9%	9.9%●	0.9%	9.7%	3.3%
NI Growth	-4.8%	59.8%	—	33.7%	112.7%●	32.9%	32.9%
Div. Yield	7.2%●	0.0%	0.2%	0.2%	2.1%	2.2%	2.1%
Payout	130.5%	0.0%	-5.9%	47.3%	30.8%	47.0%	45.7%

Valuation
Metric	PFE	BMY	GILD	AMGN	MRK	ABBV	Ind. Median
P/E	18.61	16.33●	17.86	26.09	35.84	127.27	23.37
P/B	1.55	5.92	7.00	22.15	6.98	-70.05●	4.60
EV/EBITDA	11.39	11.11●	12.22	14.91	19.37	31.12	13.81
P/S	2.20●	2.45	5.54	5.47	4.88	7.37	3.25

Financial Health
Metric	PFE	BMY	GILD	AMGN	MRK	ABBV	Ind. Median
Current Ratio	1.25	1.42	1.97●	1.26	1.30	0.80	1.25
Debt/Equity	71.5%	221.5%	94.3%	623.8%	107.1%	-1,101.9%●	94.3%
NetDebt/EBITDA	3.07	2.47	0.85●	2.71	2.31	3.75	1.35

Profitability
Metric	PFE	BMY	GILD	AMGN	MRK	ABBV	Ind. Median
Net Margin	11.8%	15.0%	31.0%●	20.9%	13.6%	5.8%	15.0%
ROE	8.3%	38.8%	43.2%	101.3%●	19.0%	—	23.7%
ROA	3.6%	8.1%	16.4%●	8.6%	7.3%	2.7%	8.0%
EBITDA Margin	26.5%	28.4%	48.7%●	44.8%	28.6%	26.9%	28.4%

Growth + Dividend
Metric	PFE	BMY	GILD	AMGN	MRK	ABBV	Ind. Median
Rev. Growth	1.4%	1.8%	3.5%	9.1%	2.5%	9.5%●	3.3%
NI Growth	-4.8%	34.2%	54.5%●	31.5%	-48.7%	-13.3%	32.9%
Div. Yield	7.2%●	4.5%	2.5%	2.7%	2.6%	2.7%	2.1%
Payout	130.5%	69.7%	43.8%	66.7%	92.1%	324.8%	45.7%

The green dot marks the best value in the group given the metric direction (higher/lower is better). All metrics use trailing-twelve-month (TTM) data.

Go deeper on PFE

Run a DCF valuation

Full DCF model with editable assumptions

Start a head-to-head duel

Compare two stocks metric by metric

Filter in the stock screener

Build your own universe with 400+ metrics

Data on this page refreshes once per day. Price data as of Jul 2, 26. This content is for informational purposes only and is not investment advice.